Changing the way people think about cancer charities by reframing the mindset towards action and transparency.

Low-Grade Serous Ovarian Cancer: Unraveling the Mystery and Finding Hope

Low-Grade Serous Ovarian Cancer: Unraveling the Mystery and Finding Hope

Low-grade serous ovarian cancer (LGSOC) is a rare subtype of ovarian cancer that often gets overshadowed by its more well-known counterpart, high-grade serous ovarian cancer….

Read This Article
Serous Borderline Tumor vs. Mucinous Borderline Tumor: What’s the Difference?

Serous Borderline Tumor vs. Mucinous Borderline Tumor: What’s the Difference?

Imagine being told you have a growth on your ovary, but it’s not quite as invasive as traditional cancer. This is the reality for many…

Read This Article
What is a PARP Inhibitor and How Does It Treat Ovarian Cancer?

What is a PARP Inhibitor and How Does It Treat Ovarian Cancer?

Ovarian cancer is a complex and challenging disease, but recent advancements in targeted therapies like PARP inhibitors are providing new hope for patients.  PARP inhibitors…

Read This Article
Hysterectomy Recovery: What Ovarian Cancer Patients Can Expect

Hysterectomy Recovery: What Ovarian Cancer Patients Can Expect

A hysterectomy is a major surgical procedure and a primary ovarian cancer treatment. While the surgery aims to remove as much of the cancerous tissue…

Read This Article
Ovarian Cancer Biomarkers: Advancing Early Detection and Guiding Treatment

Ovarian Cancer Biomarkers: Advancing Early Detection and Guiding Treatment

Ovarian cancer is a challenging disease that often develops without evident symptoms, making early detection difficult. While the impact of this cancer is significant, researchers…

Read This Article